These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26592827)

  • 1. Cancer stem cells targeting agents--a review.
    Shi AM; Tao ZQ; Li H; Wang YQ; Zhao J
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4064-7. PubMed ID: 26592827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell targets - a review.
    Zhang GF; Li CX; Liu ZQ; Ma S; Chen HB
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2045-51. PubMed ID: 27249603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taking aim at aggressive cancer cells.
    Lander E; Jiang G; Tao K
    Cancer Biol Ther; 2009 Aug; 8(16):ii. PubMed ID: 19830887
    [No Abstract]   [Full Text] [Related]  

  • 4. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
    Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salinomycin: A new paradigm in cancer therapy.
    Dewangan J; Srivastava S; Rath SK
    Tumour Biol; 2017 Mar; 39(3):1010428317695035. PubMed ID: 28349817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salinomycin as a drug for targeting human cancer stem cells.
    Naujokat C; Steinhart R
    J Biomed Biotechnol; 2012; 2012():950658. PubMed ID: 23251084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.
    Wang X; Li X; Fu X; Bai M; Li X; Mei Q; Nie J; Wu Z; Han W
    Curr Protein Pept Sci; 2015; 16(4):270-8. PubMed ID: 25929861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent.
    Antoszczak M
    Eur J Med Chem; 2019 Feb; 164():366-377. PubMed ID: 30611056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.
    Wang M; Xie F; Wen X; Chen H; Zhang H; Liu J; Zhang H; Zou H; Yu Y; Chen Y; Sun Z; Wang X; Zhang G; Yin C; Sun D; Gao J; Jiang B; Zhong Y; Lu Y
    Nanomedicine (Lond); 2017 May; 12(9):1025-1042. PubMed ID: 28440698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells.
    Pellegrini P; Dyczynski M; Sbrana FV; Karlgren M; Buoncervello M; Hägg-Olofsson M; Ma R; Hartman J; Bajalica-Lagercrantz S; Grander D; Kharaziha P; De Milito A
    Oncotarget; 2016 Jun; 7(24):35703-35723. PubMed ID: 27248168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
    Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
    Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation.
    Chan KS
    Clin Cancer Res; 2016 Feb; 22(4):802-6. PubMed ID: 26671994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.
    Riccioni R; Dupuis ML; Bernabei M; Petrucci E; Pasquini L; Mariani G; Cianfriglia M; Testa U
    Blood Cells Mol Dis; 2010 Jun; 45(1):86-92. PubMed ID: 20444629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical approaches to targeting drug resistance in cancer stem cells.
    Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
    Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
    Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
    Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salinomycin: a novel anti-cancer agent with known anti-coccidial activities.
    Zhou S; Wang F; Wong ET; Fonkem E; Hsieh TC; Wu JM; Wu E
    Curr Med Chem; 2013; 20(33):4095-101. PubMed ID: 23931281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells and chemoresistance: The smartest survives the raid.
    Zhao J
    Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.